SR 12813
SIGMA/S4194 - ≥98%, solid
Synonym: Tetraethyl 2-(3,5-di-tert-
CAS Number: 126411-39-0
Empirical Formula (Hill Notation): C24H42O7P2
Molecular Weight: 504.53
MDL Number: MFCD00888473
Linear Formula: C24H42O7P2
Product Type: Chemical
| assay | ≥98% |
| biological source | synthetic (organic) |
| form | solid |
| InChI | 1S/C24H42O7P2/c1-11-28-32 |
| InChI key | YQLJDECYQDRSBI-UHFFFAOYSA |
| originator | GlaxoSmithKline |
| Quality Level | 100 ![]() |
| SMILES string | CCOP(=O)(OCC)C(=C/c1cc(c( |
| solubility | DMSO: ≥10 mg/mL |
| H2O: insoluble |
| Application: | SR-12813 was used as control in pregnane X receptor (PXR) binding assay performed in HepG2 liver carcinoma cells and PXR-activation assay mediated by dehydroepiandrosterone in human hepatocytes. |
| Biochem/physiol Actions: | SR 12813 is a pregnane X receptor (PXR, NR 112) agonist; cholesterol lowering drug; HMGCoA reductase inhibitor. |
| Biochem/physiol Actions: | SR-12813 is a 1,1-bisphosphonate ester that exhibits hypocholesterolemic activity. It decreases the biosynthesis of cholesterol by enhancing the degradation of HMG-CoA reductase. |
| Features and Benefits: | This compound is a featured product for Gene Regulation research. Click here to discover more featured Gene Regulation products. Learn more about bioactive small molecules for other areas of research at sigma.com/discover-bsm . |
| Features and Benefits: | This compound was developed by GlaxoSmithKline . To browse the list of other pharma-developed compounds and Approved Drugs/Drug Candidates, click here . |
| Packaging: | 1, 5 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% |
| UNSPSC | 12352203 |

